At least, the implication of extracellular HSP90 in CSC phenotype regulation was clearly demonstrated for prostate cancer [102,103,104,105], breast cancer [106,107], and colorectal cancer [108]. This evidence concerns the gene HSP90AB1 and prostate cancer.